![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Heldmann, F.; Baraliakos, X.; Kiltz, U.; Brandt, J.; Horst-Bruinsma, I. E. van der; Landewe, R.; Sieper, J.; Burmester, G. R.; Bosch, F. van den; Vlam, K. de; Gaston, H.; Gruenke, M.; Witt, M.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M. und Braun, J.
(2016):
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety.
In: Clinical and Experimental Rheumatology, Bd. 34, Nr. 2: S. 184-190
Witzens-Harig, M.; Keller, U.; Viardot, A.; Buske, C.; Hönig, E.; Crombe, A.; Brandt, J.; Meissner, J.; Ho, A.; La Rosee, P.; Marks, R.; Dreyling, M. und Hess, G.
(2016):
Safety and clinical activity of temsirolimus in combination with Rituximab and DHAP in patients with relapsed or refractory diffuse large B-cell lymphoma - preliminary results of the storm trial.
In: Haematologica, Bd. 101: S. 390
Baraliakos, X.; Heldmann, F.; Callhoff, J.; Listing, J.; Appelboom, T.; Brandt, J.; Bosch, Frank van den; Breban, M.; Burmester, G. R.; Dougados, M.; Emery, P.; Gaston, H.; Grunke, M.; Horst-Bruinsma, I. E. van der; Landewe, R.; Leirisalo-Repo, M.; Sieper, J.; De Vlam, K.; Pappas, D.; Kiltz, U.; Heijde, D. van der und Braun, J.
(Oktober 2014):
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography.
In: Annals of the rheumatic diseases, Bd. 73, Nr. 10: S. 1819-1825
[PDF, 2MB]
Baraliakos, X.; Listing, J.; Brandt, J.; Zink, A.; Alten, R.; Burmester, G.; Gromnica-Ihle, E.; Kellner, H.; Schneider, M.; Sorensen, H.; Zeidler, H.; Rudwaleit, M.; Sieper, J. und Braun, J.
(2005):
Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab (vol 7, pg R439, 2005).
In: Arthritis Research & Therapy
7
[PDF, 25kB]